X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (36) 36
male (28) 28
female (27) 27
aged (24) 24
index medicus (24) 24
middle aged (22) 22
cardiac & cardiovascular systems (16) 16
prognosis (16) 16
heart failure (15) 15
atrial fibrillation (13) 13
treatment outcome (11) 11
heart failure - drug therapy (10) 10
atrial fibrillation - drug therapy (9) 9
heart failure - mortality (9) 9
italy - epidemiology (9) 9
mortality (9) 9
risk factors (9) 9
aged, 80 and over (8) 8
prevalence (8) 8
double-blind method (7) 7
heart failure - diagnosis (7) 7
risk assessment (7) 7
adult (6) 6
chronic disease (6) 6
drug therapy, combination (6) 6
endocrinology & metabolism (6) 6
heart failure - epidemiology (6) 6
heart failure - physiopathology (6) 6
hospitalization (6) 6
prospective studies (6) 6
registries (6) 6
analysis (5) 5
anti-arrhythmia agents - therapeutic use (5) 5
chronic heart failure (5) 5
double-blind (5) 5
epidemiology (5) 5
follow-up studies (5) 5
guidelines (5) 5
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (5) 5
therapy (5) 5
time factors (5) 5
acute heart failure (4) 4
anticoagulants (4) 4
atrial fibrillation - complications (4) 4
atrial fibrillation - diagnosis (4) 4
atrial fibrillation - epidemiology (4) 4
cardiovascular (4) 4
clinical trials (4) 4
drug therapy (4) 4
euro heart survey (4) 4
follow-up (4) 4
heart failure - complications (4) 4
incidence (4) 4
italy (4) 4
medicine (4) 4
morbidity (4) 4
multivariate analysis (4) 4
pharmacology & pharmacy (4) 4
practice guidelines as topic (4) 4
proportional hazards models (4) 4
recurrence (4) 4
risk (4) 4
severity of illness index (4) 4
valine - analogs & derivatives (4) 4
valsartan (4) 4
acute disease (3) 3
adolescent (3) 3
adrenergic beta-antagonists - therapeutic use (3) 3
angiotensin-converting enzyme inhibitors - therapeutic use (3) 3
anticoagulants - therapeutic use (3) 3
antithrombotic treatment (3) 3
atrial fibrillation - mortality (3) 3
atrial fibrillation - physiopathology (3) 3
cardiology (3) 3
cardiovascular diseases - etiology (3) 3
cardiovascular diseases - prevention & control (3) 3
clinical trials as topic (3) 3
diagnosis (3) 3
dose-response relationship, drug (3) 3
european-society (3) 3
fatty acids, omega-3 - therapeutic use (3) 3
fluorobenzenes - therapeutic use (3) 3
heart failure - blood (3) 3
heart failure - therapy (3) 3
hospitalization - statistics & numerical data (3) 3
kaplan-meier estimate (3) 3
management (3) 3
metaanalysis (3) 3
observational studies (3) 3
population (3) 3
practice patterns, physicians' - statistics & numerical data (3) 3
predictors (3) 3
pyrimidines - therapeutic use (3) 3
quality of life (3) 3
registry (3) 3
rosuvastatin calcium (3) 3
settore med/11 - malattie dell'apparato cardiovascolare (3) 3
stroke (3) 3
stroke volume (3) 3
sulfonamides - therapeutic use (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Handbook of Experimental Pharmacology, ISSN 0171-2004, 2017, Volume 243, pp. 15 - 33
Heart failure (HF) is a major public health problem affecting more than 23 million patients worldwide. Incidence and prevalence rates vary significantly... 
Heart failure | Registries | Prognosis | Epidemiology | Acute Disease | Prevalence | Humans | Heart Failure - physiopathology | Hospitalization | Heart Failure - drug therapy | Incidence | Stroke Volume | Chronic Disease | Heart Failure - epidemiology | Heart Failure - mortality
Journal Article
Expert Review of Cardiovascular Therapy, ISSN 1477-9072, 09/2012, Volume 10, Issue 9, pp. 1133 - 1140
Heart failure (HF) and atrial fibrillation (AF) are cardiovascular diseases that have a continuously increasing prevelance and both often coexist. The presence... 
epidemiology | heart failure | atrial fibrillation | rhythm and rate control strategies | clinical trials | observational studies | prognosis | Heart failure | Care and treatment | Usage | Prognosis | Atrial fibrillation | Analysis | Anticoagulants (Medicine) | Research | Health aspects | Epidemiology | Risk factors
Journal Article
Journal Article
by De Placido, Sabino and Gallo, Ciro and De Laurentiis, Michelino and Bisagni, Giancarlo and Arpino, Grazia and Sarobba, Maria Giuseppa and Riccardi, Ferdinando and Russo, Antonio and Del Mastro, Lucia and Cogoni, Alessio Aligi and Cognetti, Francesco and Gori, Stefania and Foglietta, Jennifer and Frassoldati, Antonio and Amoroso, Domenico and Laudadio, Lucio and Moscetti, Luca and Montemurro, Filippo and Verusio, Claudio and Bernardo, Antonio and Lorusso, Vito and Gravina, Adriano and Moretti, Anna and Moretti, Gabriella and Lauria, Rossella and Lai, Antonella and Mocerino, Carmela and Rizzo, Sergio and Nuzzo, Antonio and Nuzzo, Francesco and Carlini, Paolo and Perrone, Francesco and Accurso, Antonello and Agostara, Biagio and Aieta, Michele and Alabiso, Oscar and Alicicco, Maria Grazia and Amadori, Dino and Amaducci, Laura and Amiconi, Gianna and Antuzzi, Giustino and Ardine, Mara and Ardizzoia, Antonio and Aversa, Caterina and Badalamenti, Giuseppe and Barni, Sandro and Basurto, Carlo and Berardi, Rossana and Bergamasco, Cinzia and Bidoli, Paolo and Bighin, Claudia and Biondi, Edoardo and Boni, Corrado and Borgonovo, Karen and Botta, Mario and Bravi, Stefano and Bruzzi, Paolo and Buono, Giuseppe and Butera, Alfredo and Caldara, Alessia and Candeloro, Giampiero and Cappelletti, Claudia and Cardalesi, Cinzia and Carfora, Elisabetta and Cariello, Anna and Carrozza, Francesco and Cartenì, Giacomo and Caruso, Michele and Casadei, Virginia and Casanova, Claudia and Castori, Luigi and Cavanna, Luigi and Cavazzini, Giovanna and Cazzaniga, Marina and Chilelli, Mario and Chiodini, Paolo and Chiorrini, Silvia and Ciardiello, Fortunato and Ciccarese, Mariangela and Cinieri, Saverio and Clerico, Mario and Coccaro, Mariarosa and Comande, Mario and Corbo, Claudia and Cortino, Giuseppina and Cusenza, Stefania and Daniele, Gennaro and D'arco, Alfonso Maria and D'auria, Giuliana and Dazzi, Claudio and De Angelis, Carmine and de Braud, Filippo and De Feo, Gianfranco and De Matteis, Andrea and De Tursi, Michele and Di Blasio, Anna and di Lucca, Giuseppe and Di Lullo, Liberato and Di Rella, Francesca and Di Renzo, Gianfranco and ... and GIM Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 474 - 485
Uncertainty exists about the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors and, to our knowledge, no trial has directly... 
SYSTEM | THERAPY | EFFICACY | ONCOLOGY | FOLLOW-UP | POSTMENOPAUSAL WOMEN | COMBINATION | AROMATASE INHIBITORS | Breast cancer | Product development | Tamoxifen | Analysis
Journal Article
European journal of heart failure, ISSN 1388-9842, 2013, Volume 15, Issue 7, pp. 808 - 817
Journal Article
Arrhythmia & electrophysiology review, ISSN 2050-3369, 12/2015, Volume 4, Issue 3, pp. 163 - 168
Atrial fibrillation (AF) is the most common sustained arrhythmia in adults and is associated with an increased risk of fatal and non-fatal events.... 
post-operative atrial fibrillation | atrial fibrillation | Clinical Arrhythmias | n-3 PUFA | Arrhythmias | prevention
Journal Article
BMC Cardiovascular Disorders, ISSN 1471-2261, 04/2013, Volume 13, Issue 1, p. 28
Background: Few data on the thromboembolic (TE) risk of paroxysmal and persistent atrial fibrillation (AF) are available. This study aimed to assess the... 
Warfarin | Atrial fibrillation recurrences | Paroxysmal atrial fibrillation | Persistent atrial fibrillation | Thromboembolic risk | PREDICTING STROKE | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK STRATIFICATION | ANTITHROMBOTIC THERAPY | EURO HEART SURVEY | ANTICOAGULATION | SCHEMES | Multivariate Analysis | Recurrence | Prospective Studies | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Male | Practice Patterns, Physicians | Thromboembolism - epidemiology | Incidence | Thromboembolism - diagnosis | Warfarin - therapeutic use | Fibrinolytic Agents - adverse effects | Thromboembolism - prevention & control | Time Factors | Electrocardiography | Female | Atrial Fibrillation - diagnosis | Double-Blind Method | Hemorrhage - epidemiology | Risk Assessment | Atrial Fibrillation - drug therapy | Risk Factors | Valine - analogs & derivatives | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Chi-Square Distribution | Telemetry | Guideline Adherence | Atrial Fibrillation - epidemiology | Italy - epidemiology | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Practice Guidelines as Topic | Heart | Anticoagulants (Medicine) | Thromboembolism | Atrial fibrillation | Hypertension | Heart failure | Cardiac arrhythmia | Anticoagulants | Mortality | Clinical trials | Statistical methods | Hospitalization | Diabetes | Drug therapy
Journal Article
Journal Article
Journal of Dermatological Science, ISSN 0923-1811, 2014, Volume 77, Issue 1, pp. 54 - 62
Journal Article
Italian Journal of Medicine, ISSN 1877-9344, 2015, Volume 9, Issue 3, pp. 273 - 278
Low birth-weight (BW) is related to rise in blood pressure (BP) later in life. Aim of this study is investigating whether presence of overweight-obesity... 
Pulse pressure | Low birth-weight | Blood pressure | Male gender | Obesity-overweight | Relative risk | blood pressure | pulse pressure | male gender | obesity-overweight | relative risk
Journal Article
Journal Article
Journal Article